Biohaven CEO says drug approval is ‘monumental’ for migraine patients

cnbc2021-06-09

Biohaven CEO Vlad Coric told CNBC Tuesday a recent approval of the company’s migraine drug will “change the paradigm” of migraine prevention and treatment.The U.S. Food and Drug Administration last ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • Winkingbear
    2021-06-09
    Winkingbear
    Interesting news that’s not corona 
  • BarleyIce
    2021-06-09
    BarleyIce
    Like and comment thanksss
  • Deonc
    2021-06-09
    Deonc
    Good news
  • Yinasim
    2021-06-09
    Yinasim
    This will be good news for chronic migraine sufferers. 
    • 慢的老人
      Yes, but I am pretty sure the company will start jacking up the price for this drug now. $$$
    • Yinasim
      I guess they have to,  to recoup their R&D costs.
  • Waqwaq
    2021-06-09
    Waqwaq
    Just waiting for my neurologist to tell me about this. But the Aimovig jab works for me
  • desjen
    2021-06-09
    desjen
    Hi pls like and comment thx!
发表看法
18